Navigation Links
Imprimis Pharmaceuticals, Inc. Receives Institutional Review Board (IRB) Approval for its Phase III Clinical Trial Protocol; Phase III Clinical Trial to Begin in 3Q 2013
Date:7/22/2013

ealth and quality of life. We are delighted to be working with Dr. Neil Singla of Lotus Clinical Research, who has an excellent track record in conducting successful trials in the pain sector."

"We are excited that the Imprimis Phase III protocol was approved by an independent central ethics committee, Schulman Associates Institutional Review Board, Inc.," said Imprimis Chief Medical Officer Dr. Joachim Schupp. "This is an important milestone to commence our Phase III study in the third quarter of this year. The primary role of an IRB is to safeguard the rights, safety and welfare of participants in research. Agility Clinical and Lotus Clinical Research were instrumental in the final protocol and informed consent preparation."

"Helping innovative companies bring new treatments to patients is an important part of Agility's mission," said Ellen Morgan, CEO of Agility Clinical. "We are excited to be working with Imprimis and Lotus Clinical Research on this study. If approved, Impracor will provide patients suffering from osteoarthritis of the knee with an alternative to systemic NSAIDs for the management of their pain."

"We appreciate the opportunity to work with Imprimis Pharmaceuticals, Inc. and Agility Clinical on this important clinical trial," said Dr. Neil Singla, Owner of Lotus Clinical Research. "All parties have worked diligently over the past several months to design a robust protocol that will answer many critical regulatory and therapeutic questions concerning Impracor."

Imprimis has commenced the investigational site selection for training, qualification and study initiation.

About Imprimis Pharmaceuticals, Inc.

Imprimis Pharmaceuticals, Inc. (NASDAQ:

SOURCE Imprimis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Stephen G. Austin, CPA Joins Imprimis Pharmaceuticals Board Of Directors
2. Dr. Gerald Yakatan Joins Imprimis Pharmaceuticals Science and Regulatory Advisory Board
3. Imprimis Pharmaceuticals Signs Agreement With DPT Labs For Clinical Supplies In Advance Of Planned Phase 3 Studies For Its Ketoprofen-Based Topical Anti-Inflammatory Drug
4. Imprimis Names Two Experts To Its Science And Regulatory Board
5. Imprimis to Begin New Study of Its Topical Analgesic Drug
6. Imprimis Pharmaceuticals Announces Pricing of Public Offering of 1,840,000 Shares of Common Stock
7. Imprimis Announces Successful Results from its Pharmacokinetic Study for its Impracor Topical NSAID
8. Imprimis Announces Key Leadership Appointments
9. Imprimis Pharmaceuticals Out Licenses Its Proprietary IP to resolutionMD for Cosmeceutical Products
10. Imprimis Pharmaceuticals Announces Underwriter Exercise of Over-Allotment Option
11. Imprimis Pharmaceuticals, Inc. to Present at the National Investment Banking Association (NIBA) Conference June 18th in New York City
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... , May 22, 2015   InspireMD, Inc. ... stent embolic protection systems ("EPS"), today announced that its CGuard ... lead by principle investigator Prof. Piotr Musialek , at ... Paris, France . PARADIGM, an ... R cutaneous c A roti D revascularization I ...
(Date:5/22/2015)... Today, Rhodes Pharmaceuticals L.P. announced that Aptensio ... for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) will ... The announcement comes just one month ... Food and Drug Administration (FDA). ... capsule with an onset of effect of 1 ...
(Date:5/22/2015)... , May 22, 2015 ... phase clinical research unit with a worldwide reputation ... for its frequent publications in peer reviewed medical ... European stakeholders and regulators in discussions about rules ...      (Logo: http://photos.prnewswire.com/prnh/20150522/745125) , ...
Breaking Medicine Technology:InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 2InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 3InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 4Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 2Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 3Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 4Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 5Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 6
... Pacira Pharmaceuticals, Inc. (Nasdaq: PCRX ), ... M.D., chief medical officer, is scheduled to present at the ... Wednesday, May 25, 2011 at noon BST. Dr. Patou is ... A live audio webcast of Pacira,s presentation can be ...
... /PRNewswire-Asia/ -- Simcere Pharmaceutical Group (NYSE: SCR ... specializing in the development, manufacturing, and marketing of branded ... annual general meeting of shareholders (the "Meeting") will be ... Beijing time. The meeting will be held in No.699-18, ...
Cached Medicine Technology:Pacira Pharmaceuticals, Inc. to Present at UBS Global Specialty Pharmaceuticals Conference 2Simcere Pharmaceutical Group Provides Notice of Annual General Meeting 2
(Date:5/22/2015)... 22, 2015 According to Berks and ... drug related death, totaling almost 2,500 confirmed drug deaths, as ... state officials, totals 2,489 deaths stemming from legal and illegal ... loses seven people every day to fatal overdoses or other ... out as one of the most rife with drug related ...
(Date:5/22/2015)... Gateway Building Concepts is experienced with all forms ... specialize in include decks, additions, kitchen remodeling, interior renovations, ... more. , The redesigned logo is a fresh ... It includes two geometrical lines that represent the engineering ... be used with many things associated with the company. ...
(Date:5/22/2015)... May 22, 2015 sweetFrog Enterprises, LLC. is ... Jacksonville, Texas. Jacksonville is now the 16th sweetFrog store located ... was listed as #22 on the Inc. 500 list of ... lived and worked in East Texas for 20 years and ... owner of the Jacksonville, and nearby Palestine, sweetFrog locations. “We ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Wimbledon Health ... vascular, electrocardiogram (EKG), echocardiogram and NCV testing , ... a highly respected All American National athlete, to the ... I find the high level of testing and information ... athlete and their athletic trainers, this way they can ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Ticket Down is ... New York Rangers NHL Eastern Conference Finals Tickets . ... unless specified otherwise in the ticket listing. , For ... are at the top of the Eastern Conference. One of ... its share of ups and downs over the years, but ...
Breaking Medicine News(10 mins):Health News:Philadelphia Ranks Among the Tops Cities in Penn. for Drug Deaths 2Health News:sweetFrog Opens New Location in Jacksonville, Texas 2Health News:Wimbledon Athletics Recruits Team USA Athlete 2Health News:Wimbledon Athletics Recruits Team USA Athlete 3Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 2Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 3
... (Nasdaq: BFRM ) announced that on Thursday, December ... quarter fiscal year 2008 financial,results. The Company will issue ... and will hold a conference call with investors at ... Chief Executive Officer Steve Basta and Chief Financial Officer,Derek ...
... Activists Awarded Three-Year $5.2,Million Grant, SAN FRANCISCO, ... of the International Treatment Preparedness Coalition,and Tides, announced ... for $5.2,million from the Bill & Melinda Gates ... in advocacy and educational,activities to increase access to ...
... Tenn., Dec. 5 National partners,from the 16th ... presented more than $1.7 million of the projected ... in the fight against,childhood cancer. Companies represented at ... Wild Wings, Casey,s General Store, Fox,& Hound, Hess ...
... Donates "Asthma & Allergy Friendly" Toys to Kids ... Dec. 5 The oldest and largest,allergy patient ... Allergy,Foundation of America (AAFA), made the holidays a ... to asthma, allergies or,other respiratory diseases by donating ...
... believe,in themselves can raise their aspirations, motivation and accomplishments,and ... others do them., So says Albert Bandura, a ... won the 2008 University of Louisville,Grawemeyer Award for Psychology. ... among 31 nominations from five countries., Bandura,s ideas ...
... MYL ),today announced that Matrix Laboratories Limited* ... Drug Administration (FDA) under the,President,s Emergency Plan for ... (ANDA) for Tenofovir Disoproxil Fumarate Tablets, 300 mg.,Matrix,s ... generic,tentative approval of Gilead Sciences Inc.,s Viread Tablets, ...
Cached Medicine News:Health News:BioForm to Announce First Quarter Fiscal 2008 Financial Results and Host Conference Call and Webcast on December 13, 2007 2Health News:HIV Collaborative Fund Receives Gates Foundation Grant for AIDS Treatment and Prevention Advocacy 2Health News:HIV Collaborative Fund Receives Gates Foundation Grant for AIDS Treatment and Prevention Advocacy 3Health News:National Partners from St. Jude Halloween Promotion Presents More Than $1.7 Million to Help Fight Childhood Cancer 2Health News:Allergy Foundation Thinks Globally, Gifts Locally 2Health News:Self-Confidence Can Make Us Better, Says Grawemeyer Psychology Winner 2Health News:Mylan Announces Tentative FDA Approval Under PEPFAR for Tenofovir Disoproxil Fumarate Tablets 2
IR Autoflow Dual Chamber Over-Under Water-Jacketed CO 2 Inc....
US Autoflow Single Chamber Stackable Water-Jacketed CO2/O2 Inc....
Listeria Enrichment Broth...
... the temperature at your lab bench. This compact ... 99 C*, with the "plus" being a cooling ... The thermoblocks for 0.2 ml**, 0.5 ml, 1.0 ... high degree of flexibility for a multitude of ...
Medicine Products: